FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule...
TORONTO, March 12 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life...
Enhancements Provide Safer, Faster, and Easier Treatments OTTAWA, March 9 /PRNewswire-FirstCall/ -- MDS Nordion, a leading provider of medical...
TORONTO, March 5 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life...
Protocols developed for assay kits from Beacon Analytical Systems and Romer Labs for use on SpectraMax(R) microplate readers with SoftMax(R) Pro...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO...
SUNNYVALE, CA, Feb. 4 /PRNewswire-FirstCall/ -- MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (amend) MDS INC (Name of Issuer...
TORONTO, Feb. 2 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global...
TORONTO, Jan. 29 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.